3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Recurrence
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Lymphoma, Large B-Cell, Diffuse
4
Neoplasms
3
Lymphoma, Non-Hodgkin
3
Lymphoma, B-Cell
3
Multiple Myeloma
2
Lymphoma, Mantle-Cell
2
Leukemia, Myeloid, Acute
2
Breast Neoplasms
2
Plasmacytoma
1
Nasopharyngeal Carcinoma
1
Meningeal Carcinomatosis
1
Lymphoma
1
Liver Neoplasms
1
Leukemia
1
Glioma
1
Carcinoma, Hepatocellular
1
Burkitt Lymphoma
1
Brain Neoplasms
1
Interventions
Cyclophosphamide
13
Vincristine
10
Etoposide
8
Methotrexate
7
Doxorubicin
7
Dexamethasone
7
Cytarabine
7
venetoclax
6
Calcium Dobesilate
6
merphos
5
dexamethasone acetate
5
dexamethasone 21-phosphate
5
calaspargase pegol
5
auricularum
5
Specimen Handling
5
Prednisone
5
prednylidene
4
pegaspargase
4
deltacortene
4
Thioguanine
4
Mercaptopurine
4
Magnetic Resonance Spectroscopy
4
Leucovorin
4
Granulocyte Colony-Stimulating Factor
4
Daunorubicin
4
Asparaginase
4
fludarabine phosphate
3
daratumumab
3
azathiopurine
3
Rituximab
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
×
Immunotherapy, Adoptive
×
90 days
×
Clear all
No trials found.